A Prospective, Randomized, Double Blinded, Crossover, Two-treatment, Two-sequence, Short Term Pharmacokinetic, Pharmacodynamic and Tolerability, Single Centre Study to Compare AOP200704 vs. Esmolol in Healthy Subjects.
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2012
At a glance
- Drugs Esmolol; Landiolol
- Indications Arrhythmias
- Focus Pharmacodynamics; Pharmacokinetics
- 11 Jul 2012 Actual end date changed from Apr 2011 to Jan 2012 as reported by ClinicalTrials.gov.
- 10 Mar 2012 Actual end date (Apr 2011) added as reported by European Clinical Trials Database.
- 10 Mar 2012 Actual initiation date changed from Mar 2011 to Feb 2011 as reported by European Clinical Trials Database.